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Ent-11α-hydroxy-15-oxo-kaur-16-en-19-oic-acid (5F), an
antitumor component, is a chemical compound isolated
from Pteris semipinnata L (PsL), a Chinese traditional
herb. We examined whether 5F could affect apoptosis in
human colon cancer HT-29 cells, and test whether and
how the over-expression of Bcl-2 and Bcl-xL could off-
set the effect of 5F on cell growth. The result demon-
strated that 5F significantly induced apoptosis of HT-29,
as shown by MTT assay and DNA fragmentation mea-
surement. Treatment of HT-29 with 5F increased both p38
and iNOS levels, suggesting these two molecules may
contribute to the apoptotic effect of 5F. Over-expression
of Bcl-2 or Bcl-xL attenuated the increase of p38 and
iNOS induced by 5F. The cells with Bcl-2 or Bcl-xL over-
expression showed an elevation of nuclear factor kappa
B (NF-kappa B) activity, accompanying a significant re-
duction of 5F-induced apoptosis. Furthermore, inhibi-
tion of NF-kappa B by IkBαSR, which is a powerful in-
hibitor of NF-kappa B, restored the ability of 5F to induce
apoptosis in the cells transfected with Bcl-2. These data
strongly indicated that the apoptotic effect of 5F on HT-
29 was closely associated with the activity of NF-kappa
B, which was up-regulated by Bcl-2 and Bcl-xL. In con-
clusion, 5F induced apoptosis in HT-29 cells and this
apoptotic effect was associated with the high level of p38
and iNOS expression. The apoptotic effect of 5F could
be significantly offset by over-expression of either Bcl-
2 or Bcl-xL. Bcl-2, and to the less extent, Bcl-xL, were
able to increase the activity of NF-kappa B, which was
a known anti-apoptotic molecule in human colon cancer
cells.
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Introduction
Pteris semipinnata L (PsL) is a Chinese traditional herb,
which has been used to treat variety of inflammatory con-
ditions such as hepatitis, enteritis and snake bite.1 Re-
cently, several chemical compounds have been identified
from the ethanolic extract of the PsL. Some of these com-
pounds are able to inhibit the growth of tumor cells, in-
cluding gastric adenocarcinoma cells (MGC-803), lung
adenocarcinoma cells (SPC-A-1), human promyelocytic
leukemia cells (HL-60), nasopharyngeal carcinoma cells
(CNE-2Z), and liver adenocarcinoma cells (BEL-7402,
HepG2).2,3 Further studies reveal that PsL-induced cell
arrest is associated with reduced DNA topoisomerase,1
abnormal activation of mitogen activated protein kinase,4
decreased Bcl-2 expression and high levels of Bax, c-Foc
and c-Jun.5 However, the effect of PsL on human colon
cancer cells has not yet been investigated.
Nuclear factor kappa B (NF-kappa B), a redox-sensitive
transcription factor, is regulated by various apoptotic
stimuli or inhibitors. A number of reports have shown that
NF-kappa B is inhibited by apoptosis-inducing agents in
human colon cancer cells.6–8 Like Bcl-2 and Bcl-xL, NF-
kappa B itself may serve as a pro-survival agent in various
circumstances.9 The activation of NF-kappa B is known to
induce the expression of Bcl-2 and Bcl-xL.10–14 Inducible
loss of NF-kappa B activity is associated with the down-
regulation of anti-apoptotic Bcl-2 family members and
the occurrence of apoptosis. Furthermore, the promoter
regions of both Bcl-2 and Bcl-xL genes contain binding
sites for NF-kappa B.13–15 On the other hand, Bcl-2 can
also stimulate or restore NF-kappa B activity.16,17
In the present experiment, we examined whether ent-
11α-hydroxy-15-oxo-kaur-16-en-19-oic-acid (5F), an ef-
fective antitumor component from PsL,1–5 could affect
apoptosis in human colon cancer cells. In order to test
whether and how the over-expression of Bcl-2 and Bcl-xL
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offsets the effect of PsL on cell growth, we transfected hu-
man colon cancer cells with either Bcl-2 or Bcl-xL gene.
Materials and methods
Cell culture
A human colorectal cancer cell line, HT-29, was purchased
from American Type Culture Collection (Rockville,
Maryland), and cultured in RPMI 1640 medium (GIBCO
BRL, Grand Island, New York) containing 10% heat-
inactivated fetal bovine serum and antibiotics. Cells were
treated with either 5F or 7-hydroxystaurosporine (UCN-
01) at concentrations indicated. 5F was prepared as previ-
ous description.2–4 UCN-01 was kindly provided by the
National Cancer Institute (Rockville, MD).
Quantitation of cell death and apoptosis
An MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-dipheny-
ltetrazolium bromide] assay was used to quantify cell
death/viability. Cell death was also determined by DNA
fragmentation assay kit (Roche Molecular Biochemicals,
Mannheim, Germany), which measures apoptotic cell
death by detection of BrdU-labled DNA fragments in
the cytoplasm of affected cells. Briefly, DNA fragments
in the cytoplasm were labeled with BrdU. After the BrdU-
labeled DNA fragments were then isolated from the cells
using the solutions provided by the kit, the BrdU-labeled
DNA fragments were then detected using an enzyme-
linked immunosorbent assay (ELISA) method. The entire
assay was performed according to the manufacturer’s in-
struction. Appearance of DNA fragments has been con-
sidered as a hallmark of apoptosis. Apoptotic cells were
also evaluated by TUNEL assay using an APO-Direct
Flow Cytometry Kit from Chemicon (Temecula, CA). The
TUNEL assay was performed according to the kit instruc-
tion from Chemicon.
DNA transfection
Stable transfection was performed using cationic lipid
reagent, LipofectAMINE (Life Technologies, Rockville,
Maryland). The experiment was carried out according to
the manufacturer’s instruction. HT-29 cells (80–85% con-
fluence) were transfected with 500 ng of plasmid DNA
in serum-free conditions. After the cells were incubated
for 6 hours in serum-free medium containing DNA and
LipofectAMINE, an equal volume of growth medium con-
taining 20% serum was then added without removing
the transfection mixture. The supernatant was changed
with complete medium at 24 hours following the start of
transfection. At 72 hours after transfection, the cells were
passaged into the selective medium containing geneticin
selective antibiotic, G418. The concentration of G418 for
the selection was previously determined by dose-response
assay. Positive stably-transfected cells were selected by
G418 (0.4 mg/ml) after 2 months.
Western blot analysis
Cell samples were homogenized with ice-cold PBS and
then lysed in a solution containing 8 M urea, 0.1 M
Na2H2PO4 and 0.01 M Tris-HCl. Supernatants were ob-
tained after centrifugation at 10, 000 × g . Proteins were
separated on 10% SDS-polyacrylamide gels. Proteins were
then electrophoretically transferred from the gel onto ni-
trocellulose membranes and the membranes were blocked
for 1 hour in PBS-Tween buffer containing 5% dry milk
powder (fat free) at room temperature. The membranes
were then incubated with a primary antibody for 1 hour.
After washing, the membranes were incubated with a
secondary antibody, IgG-HRP (Santa Cruz Biotechnol-
ogy, Santa Cruz, California). Finally, they were treated
with the reagents in the chemiluminescent detection kit
(ECL system, Amersham Pharmacia Biotech, Piscataway,
New Jersey) according to the manufacturer’s instructions.
Anti-human actin antibody (Santa Cruz Biotechnology,
Santa Cruz, California) was used to detect human actin,
which was used as a control for equal loading. Anti-human
antibodies: Bcl-2, Bcl-xL, Bid, p65, cyclooxygenase-2
(COX-2), inducible nitric oxide (iNOS) and p38 mitogen-
activated protein kinase (p38 MAPK) were obtained from
Santa Cruz Biotechnology (Santa Cruz, California). The
densities of the protein bands corresponding to the size
were determined with a GSP-700 scanner with Quantity
One image software (Hercules, CA).
Nuclear protein extraction and NF-kappa B
activity assay
Nuclear protein was isolated according the procedure
described.18 Briefly, HT-29 cells were harvested, washed
in PBS, and collected by centrifugation. The cell pellet
was resuspended in 0.5 ml of 10 mM Tris-HCl (pH 7.5)/5
mM MgCl2/0.05% (v/v) Triton X-100 and lysed with
20 strokes in a homogenizer. The homogenate was cen-
trifuged at 10, 000× g for 15 minutes at 4◦C. The pellet
was obtained. The nuclei pellet volume was estimated and
the pellet was resuspended in an equal volume of 10 mM
Tris-HCl (pH 7.4)/5 mM MgCl2, followed by the addition
of 1 nuclear pellet volume of 1M NaCl/10 mM Tris-HCl
(pH 7.4)/4 mM MgCl2. The lysing nucleus was left on
ice for 30 minutes and then centrifuged at 10, 000 × g
for 15 minutes at 4◦C. The supernatant (nuclear extract)
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was removed and 80% glycerol was added so that the final
glycerol concentration was 20% (v/v). The concentration
of the nuclear protein was determined. NF-kappa B ac-
tivity was measured by an enzyme immunoassay kit from
Oxford Biomedical Research (Oxford, MI), which em-
ployed an oligonucleotide containing the DNA binding
NF-kappa B consensus sequence. If there is any NF-kappa
B presented in the sample, it will specifically bind to the
oligonucleotide coated on the plate and the DNA-bound
NF-kappa B can be selectively recognized by the antibody
to NF-kappa B subunit, p50 or p105.
Inhibition of NF-kappa B
A recombinant replication-deficient adenovirus, Ad5IkB,
contains an IkB construct in which serines 32 and 36
are mutated to alanines, driven by the cytomegalovirus
promoter-enhancer. This mutant IkB cannot be phospho-
rylated, and therefore irreversibly binds to NF-kappa B,
preventing its activation.19,20 Ad5IkB (a generous gift
from Dr. D Brenner) was used as previously described.20
The adenovirus, Ad5LacZ, which contains the Escherichia
coli β-galactosidase gene, was used as a control. Both
viruses were grown in 293 cells and purified as the pre-
vious description.20 For adenovirus infection, subconflu-
ent cells (∼80%) were infected with virus in serum-free
medium at multiplicity of infection (MOI) of 10–500 for
12 hours. The free virus was then washed off and fresh
media containing serum was added to the cells. The cells
were cultured for another 12 hours before experiments.
Statistical analysis
All values were expressed as mean ± standard error. Sta-
tistical comparisons were analyzed by the Student’s t test
using InStat software (GraphPad Software, San Diego,
California). A P -value of less than 0.05 was taken as sta-
tistically significant.
Results
5F induced cell death in dose- and
time-dependent manners
5F induced HT-29 cell death in a dose-dependent man-
ner between the concentrations of 1 and 100 mg/L (Fig-
ure 1A). At the concentration of 100 mg/L, over 95%
of the cells were dead after 48-hour treatment. The ef-
fect of 5F was also found in a time-dependent fashion
(Figure 1B). Compared with 24-hour treatment with 10
mg/L of 5F, the cell death was gradually increased to about
3.5 folds and 5.1 folds after 48-hour and 72-hour treat-
Figure 1. Cell death induced by 5F and UCN-01. After HT-29
cells were treated by 1-100 mg/L of 5F or 50–200 nM of UCN-
01 for 48 hours (A and C), the cell was harvested and the MTT
assay was performed to measure cell death. For the time-course
study, the cell was treated with either 10 mg/L of 5F or 100 nM of
UCN-01 for 24, 48 and 72 hours (B and D). At the end of the time
point, the cell death was measured by MTT assay. Control cells
were treated with vehicle only. The result of MTT was expressed
as Cell Death Index, which was calculated by the following for-
mula: [1-absorbance(test well-background)/absorbance (control-
background)] × 100%. Each experiment was repeated at least 3
times.
ments with 5F respectively. Both the dose- and the time-
dependent manners were similar to the results obtained
when the cells were treated with UCN-01 (Figures 1C
and D).
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5F upregulated the expression of p38 MAPK
and iNOS but downregulated the levels
of Bcl-2 and Bcl-xL
To understand how 5F regulates cell death, we measured
several cell death-related molecules in HT-29 cells treated
with 5F. By Western blot analysis, we found that the ex-
pression of p38 MAPK and iNOS was much higher in
the cells treated with 5F than those treated with vehicle,
whereas the levels of p65, Bcl-2 and Bcl-xL were lower
(Figure 2). The expression of COX-2 and other Bcl-2 fam-
ily members such as Bid and Bcl-xs was not different be-
tween the treatment and the control (data not shown).
The similar expression patterns of these molecules ana-
lyzed were also observed in the cells treated with UCN-01
(Figure 2). The alteration of p38 MAPK, iNOS, Bcl-2 and
Bcl-xL could be occur as early 24 hours (data not shown),
Figure 2. Effect of 5F and UCN-01 on the protein levels of p38 MAPK, iNOS, Bcl-2 and Bcl-xL. HT-29 cells were treated with 10 mg/L
of 5F or 100 nM of UNC-01 for 48 hours and then cell lysates were obtained for Western blot analysis of p38 MAPK (38 KDa), iNOS
(130 KDa), p65 (65 KDa); Bcl-2 (28 KDa) and Bcl-xL (32 KDa). Actin protein (43 KDa), which is constitutively expressed, was used as a
control. The densities of the protein bands corresponding to the size were determined and the relative amount of the target protein was
shown as Expression Index, which was calculated by the formula: the density of the control (actin) band/ the density of the target band.
which predated the activation of caspase-3. Time course
study showed that a slight increase in 32 kDa caspase-3 at
36 hours and the active caspase-3 (20 kDa) did not appear
until 48 hours after 5F treatment (Figure 3).
Over-expression of Bcl-2 and Bcl-xL protected
cell death induced by 5F
To investigate how the over-expression of Bcl-2 and Bcl-
xL affects the cell death in HT-29 induced by 5F, we
transfected HT-29 cells with Bcl-2, Bcl-xL, or pcDNA3.1
plasmids and the cells were named as HT-29/Bcl-2, HT-
29/Bcl-xL and HT-29/mock cells respectively. Positive
clones were selected by G418 and the over-expression
of Bcl-2 or Bcl-xL was confirmed using Western blot
(Figure 4). In order to clarify whether the over-expression
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Figure 3. Time-course study of caspase-3 expression. HT-29 cells were treated with 10 mg/L of 5L and cell lysates were obtained at
0 (without 5L treatment), 24, 36, 48 and 60 hours for protein analysis. Detection of caspase-3 protein was performed using the ECL
Western blotting detection system.
Figure 4. Over-expression of Bcl-2 and Bcl-xL in HT-29. After
stable transfection, HT-29/Bcl-2 and HT-29/Bcl-xL cells were es-
tablished. Cell lysates were isolated from the cells and Bcl-2 (28
KDa) and Bcl-xL (32 KDa) levels were determined by Western blot
analysis. A: The cells transfected with Bcl-2 or Bcl-xL genes; B:
The cells transfected with an empty vector.
of Bcl-2 or Bcl-xL in HT-29 cells blocks the chemical
induction of apoptosis, HT-29/Bcl-2, HT-29/Bcl-xL and
HT-29/mock cells were treated with a known cell death
inducer, UCN-01 (Figure 5). Following treatment, cell
death was measured by MTT assay. The result showed
that HT-29/Bcl-2 and HT-29/Bcl-xL cells had a signif-
icantly higher percentage of living cells compared to
HT-29/mock cells (Figure 5A), indicating that the HT-
29/Bcl-2 and HT-29/Bcl-xL transfectants were functional.
These cells were then treated with 10 mg/L of 5F (Figure
5B). While HT-29/mock cells displayed marked death in
response to 5F treatment, HT-29/Bcl-2 and HT-29/Bcl-
xL cells showed approximately 95% and 90% protection
from 5F-induced death respectively. The cell death in-
duced by either 5F or UCN-01 was mainly caused by
apoptosis, as the similar result was obtained by DNA
fragmentation assay (Figures 5C and D). The occurrence of
DNA fragment is a typical Marker for apoptosis. Apopto-
sis was further confirmed by TUNEL assay (APO-Direct
Flow Cytometry Kit, Chemicon, Temecula, CA). After
5F treatment, HT-29/Bcl-2 and HT-29/Bcl-xL cells ex-
hibited only 1.51% and 0.25% of apoptotic cells while
the control cells (without treatment or vector transfection
only) showed average 82.46% of apoptotic cell death, sug-
gesting that 5F could offer 98–99% protection against the
cytotoxic effect of 5F.
Over-expression of Bcl-2 and Bcl-xL increased
NF-kappa B activity
NF-kappa B activity is known to be closely associated with
Bcl-2 and Bcl-xL expression.10–14,16,17 In order to deter-
mine how the over-expression of Bcl-2 and Bcl-xL affects
the NF-kappa B activity in HT-29 cells treated either 5F
or UCN-01, the cells transfected with either Bcl-2 or Bcl-
xL were incubated with 10 mg/L of 5F, 100 nM of UCN-
01 or vehicles. The nuclear protein was isolated after in-
cubation. The cells transfected with an empty pcDNA3.1
vector and the cells without any transfection were used as
controls. NF-kappa B activity was significantly higher in
the cells with Bcl-2 or Bcl-xL (Figure 6). It appeared that
Bcl-2 was more effective in raising NF-kappa B activity
than Bcl-xL.
Inhibition of NF-kappa B offsetted the protective
effect offered by Bcl-2 and Bcl-xL
Since the over-expression of Bcl-2 and Bcl-xL increased
the activity of NF-kappa B and protected the cells from
apoptosis induced by 5F and UCN-01, it would be in-
teresting to know whether the inhibition of NF-kappa
B activity could diminish the protective effect offered by
Bcl-2 and Bcl-xL. A super-repressor of NF-kappa B activ-
ity (Ad5IkB), which is a mutated non-degradable IkBα
resistant to phosphorylation and degradation, was used to
inhibit the activity of NF-Kappa B. Previous experiments
have demonstrated that this super-repressor was capable
of inhibiting the activity of NF-kappa B in HT-29 cells.
HT-29/Bcl-2 cells regained their sensitivity to apoptosis
induced by 5F after being treated by Ad5IkB (Figure 7A).
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Figure 5. Protection of cell death induced by UCN-01 and 5F
with Bcl-2 or Bcl-xL. HT-29 cells with extraneous genes (Bcl-2 or
Bcl-xL) or without were incubated with 10 mg/L of 5F (B and D),
100 nM of UCN-01 (A and C) or vehicles for 48 hours. The cell
death was measured by the MTT assay (A and B). The result of
MTT was expressed as Cell Death Index (see Figure 1 for de-
tails). The cell apoptosis was determined by DNA fragmentation
detection assay (C and D). DNA fragments from damaged cells
were released into the culture supernatant and labeled by BrdU.
The BrdU-labled DNA was quantified using a monoclonal antibody
against BrdU. Each point represents a mean of three independent
experiments with triplicate wells. The result of DNA fragmenta-
tion detection assay was expressed as Apoptotic Index, which
was calculated by the following formula: [1-absorbance(test well-
background)/absorbance (control-background)]× 100%. #NT: No
(UNC-01 or 5F) treatment. ∗∗ p < 0.01,∗ p < 0.05 compared with
the controls.
However, a significant portion of HT-29/Bcl-xL cells was
not protected after treated by Ad5IkB (Figure 7A), sug-
gesting that Bcl-xL could still function, to a certain de-
gree, to protect the cells from death when the activity of
Figure 6. NF-kappa B activity in the cells with Bcl-2 and Bcl-
xL over-expression. HT-29 cell culture was the same as that de-
scribed in Figure 4 and cells were with 10 mg/L of 5F (B), 100
nM of UCN-01 (A) or vehicles for 48 hours. After culture, the nu-
clear protein was isolated for the determination of NF-kappa B
activity, which was measured by a commercially-available ELISA
kit. Each point represents a mean of three independent experi-
ments with triplicate wells. #NT: No (UNC-01 or 5F) treatment.
∗∗ p < 0.01,∗ p < 0.05 compared with the controls.
Figure 7. Attenuation of Bcl-2 and Bcl-xL protection by the inhi-
bition of NF-kappa B activity. The cells were infected with either
Ad5IkB or Ad5LacZ, as described in Methods. After the infection,
the cells were stimulated with 5 F 10 mg/L of 5F (A), 100 nM
of UNC-01 (B) or vehicle alone for 48 hours. The cell death was
measured by the MTT assay. The result of MTT was expressed
as Cell Death Index (see Figure 1 for details). #NT: No (UNC-01
or 5F) treatment.
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NF-kappa B was inhibited. Somewhat different from 5F,
cell death induced by UCN-01 in both HT-29/Bcl-2 and
HT-29/Bcl-xL cells were prevented when the cells were
treated by Ad5IkB (Figure 7B), indicating that both Bcl-
2 and Bcl-xL lost their anti-apoptotic effects when the
activity of NF-kappa B was suppressed.
Discussion
Although 5F, a chemical component isolated from PsL, has
been known to inhibit the growth of several types of tumor
cells,1–5 the mechanism is not yet clear and its effect on
human colon cancer cells has not yet been studied before.
In the present study, we demonstrated that 5F was able to
induce cell death via an apoptotic pathway and in a similar
manner to UCN-01. UCN-01 was originally identified as
a more specific inhibitor of protein kinase C (PKC) than
the parent compound staurosporine.21,22 However, the in-
hibition of PKC is unlike to be responsible for its effect
on the cell growth arrest. UCN-01 showed the growth-
inhibitory effect against malignant cells, as demonstrated
in the present and others’ studies.23,24 UCN-01 is cur-
rently undergoing clinical evaluation as an antitumor
drug in the United State and Japan. 5F at the concen-
tration of 10 mg/L seems to be able to achieve the same
efficiency of UCN-01 at 100 nM, as both drugs at these
concentrations induced a similar number of cell death and
also they were able to generate very similar time-course
curves. Therefore, by comparing 5F with a well-known
cell growth inhibitor, such as UCN-01, it will help us to
evaluate whether 5F can be considered to be an anti-cancer
agent.
In the present study, we found that a number of
molecules were altered at protein levels in human colon
cancer cells treated by 5F. Both p38 MAPK and iNOS
were increased by either 5F or UCN-01 treatment. It is
widely accepted that iNOS is a main enzyme responsible
for a large amount of nitric oxide (NO) production. NO is
apoptosis-inducer in a variety of human cells and has been
a target for novel therapy in a number of malignant cells.
For example, in human gastric cancer, NO contributes to
the tumouricidal activity of 5-fluorouracil.25 In human
colon cancer cells, NO generated by interferon-gamma
and tumor necrosis factor alpha induces cell death.26 NO
donors, such as glyceryl trinitrate, are known to induce
apoptosis via a pathway related to activating caspase cas-
cade, increasing the expression of Fas and decreasing the
expression of several inhibitors of apoptosis (IAPs).27 The
production of NO is closely associated with p38 MAPK.
p38 MAPK is involved in the generation of NO, at least,
at two points. First, the p38 MAPK pathway can enhance
NO production by increasing the intracellular concentra-
tion of the substrate for NO synthetase via stimulation
of arginine transporter activity.28 Second, p38 MAPK
activity is required for the increased gene expression of
iNOS.29 In addition, activation of p38 MAPK is also in-
volved in the NO-induced apoptosis by relaying NO sig-
nal to its down stream apoptotic molecules including p53,
cytochrome c and caspases.30,31 The increased p38 MAPK
and NO levels are reported to participate cell death in-
duced by UCN-01,23,32 which is in line with the current
findings. Therefore, the result of increased iNOS and p38
MAPK is thought to contribute to the cell death induced
by 5F.
NF-kappa B has recently emerged as a major player
in a variety of human cancers mainly because of its abil-
ity to protect transformed cells from apoptosis. There is
increasing evidence to support a role for NF-kappa B in
tumorigenesis of colon cancer and to document that the
inhibition of NF-kappa B suppresses the growth of colon
cancer cells via an apoptotic pathway,6,7,33,34 which is
impaired during colon cancer development.6,35 Dietary
flavone dramatically reduced NF-kappa B activity, to-
gether with COX-2 levels.34 The reduction was displayed
a high selectivity for the induction of apoptosis and of
growth inhibition. The mechanism of 5F on human colon
cancer cells may be different from flavone, as it didn’t
change the COX-2 expression though it did reduce the
activity of NF-Kappa B. We found that accompanying the
decreased NF-kappa B activity by 5F was the reduction of
two anti-apoptotic Bcl-2 family members, Bcl-2 and Bcl-
xL. The finding is not surprising, as both the promoter
regions of Bcl-2 and Bcl-xL genes contain binding sites
for NF-kappa B and thus their expression is controlled
by the activity of NF-kappa B.13–15 It has been reported
that NF-kappa B activity is negatively associated with p38
MAPK. In human melanoma cells, p38 MAPK suppresses
NF-kappa B activity, which sensitizes melanoma cells
to UV-, ribotoxic and radiomimetic chemicals-induced
apoptosis.36 Although 5F also reduces NF-kappa B activ-
ity and elevates the level of p38 in human colon cancer
cells, the pathway linked these two molecules needs fur-
ther study.
The decreased NF-kappa B activity, the reduction of
Bcl-2 and Bcl-xL levels and the increased p38 and iNOS
expression in the colon cancer cells treated with 5F were
in agreement with a significantly increase in the number
of cell death and the amount of DNA fragmentation, a
classic indicator of apoptosis. In order to further support
our findings, we transfected the cells with Bcl-2 or Bcl-
xL genes and tested how these transfectants behaved in
response to 5F stimulation. After transfection with either
Bcl-2 or Bcl-xL, the cells showed a significant resistance
to the 5F treatment and the percentage of cell death was
markedly different from those without Bcl-2 or Bcl-xL
transfection. And also the activity of NF-kappa B was sig-
nificantly higher in the cells with Bcl-2 or Bcl-xL genes.
The current result may support the notion proposed by
the previous reports that Bcl-2 overexpression preserves
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or restores NF-kappa B and thus inhibits apoptosis.16,37
Furthermore, using a super-repressor of NF-kappa B, the
cells with Bcl-2 transfection re-gained their sensitivity
to 5F treatment. However, the cells with Bcl-xL over-
expression failed to have full recovery of their sensitivity
to the drug stimulation. Therefore, it appears that the
protective mechanism of Bcl-2 and Bcl-xL is different, to
some extent, in colon cancer cells in response to 5F stim-
ulation, with the former being much more NF-kappa B-
dependent than the latter. This is also one aspect that is
different between 5F and UCN-01, whose treatment led
to the similar level of NF-kappa B-dependent inhibition
in the cells with the over-expression of either Bcl-2 or
Bcl-xL. The mechanism accounting for the different lev-
els of NF-kappa B-dependence in the cells with Bcl-2 and
Bcl-xL over-expression is worth further investigating.
Though both 5F and UCN-01 can offer anti-cancer ef-
fects probably via a similar mechanism, it is not clear what
the advantage is of using 5F in comparison to UCN-01.
However, in vivo study of UCN-1 has shown that UCN-
01 can generate a number of side- or toxicological effects
such as body weigh lose, leucopenia, bone marrow deple-
tion and lymphoid tissue atrophy.38 Traditional Chinese
herb medicine is usually tranquil. Nevertheless, further
studies need to evaluate 5F as an anti-cancer agent and
also its side effects.
Conclusion
5F induced apoptosis in HT-29 cells and this apoptotic ef-
fect was associated with the high level of p38 and iNOS ex-
pression. The apoptotic effect of 5F could be significantly
offset by over-expression of either Bcl-2 or Bcl-xL. Bcl-2,
and to the less extent, Bcl-xL, were able to increase the ac-
tivity of NF-kappa B, which was a known anti-apoptotic
molecule in human colon cancer cells. Inhibition of NF-
kappa B can restore the ability of 5F to induce apoptosis.
Therefore, apoptotic effect of 5F on colon cancer cells is
closely related to the activity of NF-kappa B.
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